S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
NASDAQ:AMED

Amedisys (AMED) Stock Forecast, Price & News

$93.40
+0.14 (+0.15%)
(As of 09/29/2023 ET)
Compare
Today's Range
$93.24
$93.73
50-Day Range
$89.84
$94.08
52-Week Range
$69.36
$106.56
Volume
189,802 shs
Average Volume
408,347 shs
Market Capitalization
$3.05 billion
P/E Ratio
1,334.48
Dividend Yield
N/A
Price Target
$109.67

Amedisys MarketRank™ Forecast

Analyst Rating
Hold
2.23 Rating Score
Upside/​Downside
17.4% Upside
$109.67 Price Target
Short Interest
Bearish
6.91% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.61
Upright™ Environmental Score
News Sentiment
0.47mentions of Amedisys in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.23%
From $4.48 to $4.58 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.77 out of 5 stars

Medical Sector

821st out of 972 stocks

Home Health Care Services Industry

6th out of 7 stocks


AMED stock logo

About Amedisys (NASDAQ:AMED) Stock

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

AMED Price History

AMED Stock News Headlines

StockNews.com Begins Coverage on Amedisys (NASDAQ:AMED)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Amedisys Sees Unusually Large Options Volume (NASDAQ:AMED)
Amedisys (NASDAQ:AMED) Now Covered by Analysts at StockNews.com
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Travis Messina named CEO of Regent Surgical Health
What 11 Analyst Ratings Have To Say About Amedisys
Amedisys: Q2 Earnings Snapshot
Amedisys (AMED) Tops Q2 Earnings Estimates
Jefferies Downgrades Amedisys (AMED)
Benchmark Downgrades Amedisys (AMED)
See More Headlines
Receive AMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amedisys and its competitors with MarketBeat's FREE daily newsletter.

AMED Company Calendar

Last Earnings
7/26/2023
Today
10/01/2023
Next Earnings (Estimated)
10/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
Current Symbol
NASDAQ:AMED
CUSIP
02343610
Employees
20,000
Year Founded
1982

Price Target and Rating

Average Stock Price Forecast
$109.67
High Stock Price Forecast
$165.00
Low Stock Price Forecast
$81.00
Forecasted Upside/Downside
+17.4%
Consensus Rating
Hold
Rating Score (0-4)
2.23
Research Coverage
13 Analysts

Profitability

Net Income
$118.61 million
Pretax Margin
2.18%

Debt

Sales & Book Value

Annual Sales
$2.22 billion
Cash Flow
$7.26 per share
Book Value
$34.06 per share

Miscellaneous

Free Float
32,046,000
Market Cap
$3.05 billion
Optionable
Optionable
Beta
1.00

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Scott G. GinnMr. Scott G. Ginn (Age 54)
    Exec. VP, COO, CFO & Principal Financial Officer
    Comp: $659.94k
  • Mr. Michael P. NorthMr. Michael P. North (Age 58)
    Chief Information Officer
    Comp: $442.38k
  • Ms. Denise  BohnertMs. Denise Bohnert (Age 45)
    Chief Compliance Officer
    Comp: $399.72k
  • Mr. Nick Muscato (Age 37)
    Chief Strategy Officer
    Comp: $400.94k
  • Mr. Richard M. Ashworth (Age 48)
    Pres, CEO & Director
  • Ms. Allyson Guidroz
    Chief Accounting Officer & Principal Accounting Officer
  • Mr. Pete Hartley
    CTO & Sr. VP of Bus. Operations Systems
  • Ms. Jennifer Guckert Griffin
    Sr. VP, Deputy Gen. Counsel, Corp. Sec. & Interim Chief Legal Officer
  • Kendra Kimmons
    VP of Marketing & Communications & Media Relations
  • Mr. Adam Holton (Age 52)
    Chief People Officer













AMED Stock - Frequently Asked Questions

Should I buy or sell Amedisys stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amedisys in the last twelve months. There are currently 10 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AMED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMED, but not buy additional shares or sell existing shares.
View AMED analyst ratings
or view top-rated stocks.

What is Amedisys' stock price forecast for 2023?

13 brokerages have issued 1-year price targets for Amedisys' stock. Their AMED share price forecasts range from $81.00 to $165.00. On average, they expect the company's stock price to reach $109.67 in the next twelve months. This suggests a possible upside of 17.4% from the stock's current price.
View analysts price targets for AMED
or view top-rated stocks among Wall Street analysts.

How have AMED shares performed in 2023?

Amedisys' stock was trading at $83.54 at the beginning of the year. Since then, AMED shares have increased by 11.8% and is now trading at $93.40.
View the best growth stocks for 2023 here
.

Are investors shorting Amedisys?

Amedisys saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 2,080,000 shares, an increase of 26.1% from the August 31st total of 1,650,000 shares. Based on an average daily volume of 445,800 shares, the short-interest ratio is presently 4.7 days. Currently, 6.9% of the company's shares are sold short.
View Amedisys' Short Interest
.

When is Amedisys' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our AMED earnings forecast
.

How were Amedisys' earnings last quarter?

Amedisys, Inc. (NASDAQ:AMED) posted its earnings results on Wednesday, July, 26th. The health services provider reported $1.37 EPS for the quarter, beating the consensus estimate of $1.09 by $0.28. The health services provider had revenue of $552.97 million for the quarter, compared to analysts' expectations of $568.18 million. Amedisys had a trailing twelve-month return on equity of 14.00% and a net margin of 0.10%. The company's revenue for the quarter was down .9% on a year-over-year basis. During the same period in the prior year, the business earned $1.47 EPS.

What ETFs hold Amedisys' stock?
What is Paul B. Kusserow's approval rating as Amedisys' CEO?

478 employees have rated Amedisys Chief Executive Officer Paul B. Kusserow on Glassdoor.com. Paul B. Kusserow has an approval rating of 79% among the company's employees. 60.0% of employees surveyed would recommend working at Amedisys to a friend.

What other stocks do shareholders of Amedisys own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amedisys investors own include NVIDIA (NVDA), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Adobe (ADBE), Intel (INTC), QUALCOMM (QCOM), Broadcom (AVGO), Cisco Systems (CSCO) and Home Depot (HD).

What is Amedisys' stock symbol?

Amedisys trades on the NASDAQ under the ticker symbol "AMED."

How do I buy shares of Amedisys?

Shares of AMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Amedisys' stock price today?

One share of AMED stock can currently be purchased for approximately $93.40.

How much money does Amedisys make?

Amedisys (NASDAQ:AMED) has a market capitalization of $3.05 billion and generates $2.22 billion in revenue each year. The health services provider earns $118.61 million in net income (profit) each year or $0.07 on an earnings per share basis.

How many employees does Amedisys have?

The company employs 20,000 workers across the globe.

How can I contact Amedisys?

Amedisys' mailing address is 3854 AMERICAN WAY SUITE A, BATON ROUGE LA, 70816. The official website for the company is www.amedisys.com. The health services provider can be reached via phone at (225) 292-2031, via email at ir@amedisys.com, or via fax at 225-292-8163.

This page (NASDAQ:AMED) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -